Large Cap Archives - Page 340 of 437

1 minute read

RPM Q3 Sales & EPS Exceed Expectations; Q4 Guidance Muted On Ongoing Economic Challenges

April 6, 7:59 AM

RPM International Inc (NYSE:RPM) reported third-quarter FY23 sales growth of 5.7% year-over-year to $1.52 billion, exceeding the consensus of $1.47 billion. Sales…

RPM

2 minute read

Dollar General’s Key Initiatives Should Boost Top line Growth in 2023, But Lower-Income Consumer Base and Low Tax Refunds a Concern: Analyst

By Lekha Gupta

April 5, 3:13 PM

Truist Securities analyst Scot Ciccarelli reiterated Hold Rating on Dollar General Corp. (NYSE:DG) and a price target at $214. The analyst…

1 minute read

Final Medicaid Rates Announcement Is Good For UnitedHealth – Analyst Upgrades Stock, Sees Strong Upside

By Lekha Gupta

April 5, 2:28 PM

Raymond James upgraded the rating on UnitedHealth Group Inc (NYSE:UNH) to Strong Buy from Outperform while raising the price target to $630 from…

UNH

2 minute read

Walmart’s Supply Chain Revolution: A Wake-Up Call For Target And TJ Maxx?

By AJ Fabino

April 5, 12:45 PM

Retail behemoth Walmart Inc (NYSE: WMT) made waves at its two-day 2023 Investment Community meeting.

TGT

4 minute read

Facebook Turns To Generative AI For Help, FedEx Consolidates, UBS Executives Say Surprise Credit Suisse Deal ‘Major Challenge:’ Today’s Top Stories

By Vandana Singh

April 5, 9:39 AM

Benzinga

AAPL

1 minute read

After Failing For Third Time, Exxon Ends Oil Drilling In Brazilian Offshore Waters

By Vandana Singh

April 5, 9:19 AM

Exxon Mobil Corp (NYSE: XOM) has reportedly stopped drilling in the offshore acreage after failing to find commercially viable amounts of crude in Brazil's deep waters for the third time.

EQNR

1 minute read

ConAgra Brands Q3 Highlights: 5.9% Sales growth, Earnings Beat, Margin Recovery, FY23 EPS Guidance Boost & More

By Lekha Gupta

April 5, 8:33 AM

ConAgra Brands Inc (NYSE:CAG) reported third-quarter FY23 sales growth of 5.9% year-on-year to $3.087 billion, broadly in line with the…

CAG

1 minute read

AstraZeneca’ Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study

By Vandana Singh

April 5, 6:45 AM

AstraZeneca Plc (NASDAQ:AZN) announced topline data from a planned interim analysis of the DUO-O Phase 3 trial of a combination of…

AZN

1 minute read

Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots

By Vandana Singh

April 4, 2:08 PM

Arbutus Biopharma Corporation (NASDAQ:ABUS) and its licensee Genevant Sciences have sued Pfizer Inc (NYSE:PFE) and its partner BioNTech SE (NASDAQ:BNTX) in the U.S. District Court…

ABUS

2 minute read

KeyBanc Capital Markets Touts WOW And CMCSA, Cautions Patience On CHTR: Analysts Explain Why

By AJ Fabino

April 4, 11:25 AM

KeyBanc Capital Markets on Monday adjusted its ratings on several Cable and Wireless stocks after analyzing first-quarter conferences and engaging in discussions with key investors.

ATUS